Effect of a novel bioceramic root canal sealer on the angiogenesis-enhancing potential of assorted human odontogenic stem cells compared with principal tricalcium silicate-based cements Objective: This study evaluated the angiogenesis-enhancing potential of a tricalcium silicate-based mineral trioxide aggregate (ProRoot MTA), Biodentine, and a novel bioceramic root canal sealer (Well-Root ST) in human dental pulp stem cells (hDPSCs), human periodontal ligament stem cells (hPLSCs), and human tooth germ stem cells (hTGSCs). Methodology: Dulbecco's modified Eagle's medium was conditioned for 24 h by exposure to ProRoot MTA, Biodentine, or Well-Root ST specimens (prepared according to the manufacturers' instructions). The cells were cultured in these conditioned media and their viability was assessed with 3-(4,5-dimethyl-thiazol-2-yl)-5-(3-carboxy-methoxy-phenyl)-2-(4-sulfo-phenyl)-2H tetrazolium (MTS) on days 1, 3, 7, 10, and 14. Angiogenic growth factors [platelet-derived growth factor (PDGF), basic fibroblast growth factor (FGF-2), and vascular endothelial growth factor (VEGF)] were assayed by sandwich enzyme-linked immunosorbent assay (ELISA) on days 1, 7, and 14. Human umbilical vein endothelial cell (HUVEC) migration assays were used to evaluate the vascular effects of the tested materials at 6-8 h. Statistical analyses included Kruskal-Wallis, Mann-Whitney U, and Friedman and Wilcoxon signed rank tests. Results: None of tricalcium silicate-based materials were cytotoxic and all induced a similar release of angiogenic growth factors (PDGF, FGF-2, and VEGF) (p>0.05). The best cell viability was observed for hDPSCs (p<0.05)
Introduction
Guided endodontic repair refers to regenerative therapies that have as their first priorities: periapical lesions healing, root development promotion, root canal walls thickening, and apical foramen maturation induction to maintain dental pulp vitality. These steps in the repair process are essential to ensure the repaired teeth durability and functionality.
Wound healing and repair depend on angiogenesis to promote neovascularization. 1 The angiogenic response is controlled by the cumulative effects of positive and negative regulatory factors. 2 In particular, a role for a number of polypeptide growth factors has been identified in the initiation of the angiogenic response and regulation of endothelial cell proliferation in wound healing. 3 These factors include basic fibroblast growth factor (FGF-2), platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF; which is also designated as vascular permeability factor and fibroblast growth factor). VEGF is considered essential for the vascular system differentiation. 4 Similarly, FGF-2 stimulates new blood vessels growth and development (angiogenesis) that contribute to normal wound healing and tissue development 5 and plays a significant role in the neovascularization of damaged or traumatized tissue, 6 whereas PDGF functions in tissue regeneration and embryogenesis. VEGF production also provides important information regarding cells functionality. 7 Scientific literature indicates that these growth factors possibly participate in the angiogenic response of the dental pulp and periapical tissues; therefore, their role in regenerative or vital pulp therapies needs further exploration. In this respect, a key goal of relevant research should be to discern the interaction between bioactive endodontic materials and the growth factors released during regeneration and/or revascularization, as well as their effects on the angiogenic responses of adjacent tissues.
Guided endodontic repair has been conducted for many years in Dentistry using mineral trioxide aggregate (MTA) and other bioactive endodontic materials. 8, 9 MTA has been recognized as the approved gold standard in guided endodontic repair therapies for many years because of its capacity to induce smooth hard tissue deposition with low pulpal inflammation 10 and for its biocompatibility on cells regarding its reparative, regenerative, and angiogenic effects. 11, 12 However, novel tricalcium silicate-based cements, such as Biodentine (Septodont,. Saint-Maur-des-Fossés, France), have recently been introduced to overcome the somewhat intolerable drawbacks of MTA, such as its long setting time, 13 difficult handling properties, 13 and tooth discoloration. 14 Biodentine was produced using active biosilicate technology to serve as a bioactive dentin substitute. 13 The mixture is prepared in a powder-to-liquid form in a single-dose capsule, to be mixed with an amalgamator for 30 s. The cement is then applied to the cavity as a bulk dentin substitute without any requirement for adhesive technology. 15 The calcium chloride content of Biodentine leads to a much shorter setting time (12 min) than ProRoot MTA (3-4 h), superior handling characteristics, and enhanced angiogenic and osteogenic capacity when administered to human mesenchymal stem cells. 12 These beneficial factors support the Biodentine use as an agreeable alternative bioactive material for use in guided endodontic repair.
One recently developed alternative is Well-Root ST (Vericom, Gangwon-Do, Korea), a premixed, ready to use, and injectable bioactive root canal sealer based on tricalcium silicate, which is a hydrophilic sealer that requires water presence to set and harden. The setting time is 25 min, measured according to ISO 6876:2012 (100% humidity conditions). However, in normal root canals, the setting time can be more than 2.5 h as reported by the manufacturer. To our knowledge, no information has been published in scientific literature regarding the angiogenic capacity of this root canal sealer.
Our main objective was, therefore, to compare the in vitro cellular angiogenic responses of human dental pulp stem cells (hDPSCs), human periodontal ligament stem cells (hPLSCs), and human tooth germ stem cells (hTGSCs) when exposed to ProRoot MTA, Biodentine, and Well-Root ST. A second objective was to show the vascular effects of these materials on human umbilical vein endothelial cells (HUVECs) using the Matrigel-based tube formation assay. Three null hypotheses were tested: (1) The angiogenic response of hDPSCs, hPLSCs, and hTGSCs after their exposure to tricalcium silicate-based cements is not different; 
Discs of tricalcium silicate-based cements and Dycal
were immersed in Dulbecco's modified Eagles' medium (DMEM) for 24 h. A medium that had not been treated with the cement materials served as a negative control for ELISA, tube formation assays, and MTS assays, and a medium treated with Dycal was used as a positive control for the tube formation and MTS assays.
Isolation of hTGSCs, hDPSCs, and hPDLSCs and cell culture conditions
The hTGSCs, hDPSCs, and hPLSCs were isolated and characterized as described previously; [16] [17] [18] The hTGSCs were collected from the mandibular third molar tooth, and the hDPSCs and hPDLSCs were collected from maxillary second premolar teeth of Flow cytometry-based mesenchymal stem cell characterization Isolated hTGSCs, hDPSCs, and hPDLSCs (passage 3) were characterized for their mesenchymal cell surface profiles, as described previously. [16] [17] [18] The hTGSCs and hDPSCs were trypsinized and incubated with the following conjugated antibodies: CD29, CD34, CD45, CD73, CD90, CD105, CD133, and CD166 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). The hPDLSCs were then incubated with primary antibodies raised against STRO-1, CD146, CD90, CD44, CD19, or CD14. The cells were washed with phosphate-buffered saline (PBS) to remove the excess primary antibodies. The cells were analyzed by flow cytometry using a FACSCalibur flow cytometry system (Becton Dickinson, San Jose, CA, USA).
Material

MTS cell viability assays
Cell viability was measured on the 1 st , 3 rd , 7 th , 10 th , and 14 th days, using the 3-(4,5-dimethyl-thiazol-2-yl)- 
Tube formation assay
A Matrigel-based tube formation assay was performed as described previously to show the vascular effects of tricalcium silicate-based cements. 19 Frozen growth factor-reduced Matrigel (BD Bioscience) was warmed up to room temperature, and 150 μL was plated onto 48-well plates on ice so that Matrigel covered the plate surface, and the plates were In the hTGSCs group, cell viability was significantly enhanced by Well-Root ST, Biodentine, and ProRoot MTA when compared with Dycal and the control groups at day three (p<0.05). However, on the first, seventh, tenth and fourteenth day, the MTS levels in all groups showed no statistically significant differences except for the Dycal group, which showed lower cell viability (p>0.05).
Results
Cell attachment and viability
The hDPSCs group showed the following Effect of a novel bioceramic root canal sealer on the angiogenesis-enhancing potential of assorted human odontogenic stem cells compared with principal tricalcium silicate-based cements 
ELISA
The hTGSC, hDPSC, and hPLSC groups showed no statistically significant differences in FGF-2, PDGF, and VEGF levels between the first, seventh, and fourteenth days when exposed to the test materials (p>0.05).
The ELISA results for FGF-2, PDGF, and VEGF are shown in Figure 3 compared to the other test materials (p>0.05). At the fourteenth day, the VEGF levels were higher in the ProRoot MTA and Biodentine groups than in the Well-Root ST and control groups (p>0.05). In the hPLSCs, the VEGF levels were higher in the Biodentine and Well-Root ST groups at the first and seventh days, and especially at first day, but at the fourteenth day, the VEGF levels were higher for ProRoot MTA than for the other tested materials, although the difference did not reach statistical significance (p>0.05). The highest FGF-2 levels were obtained with Biodentine in hTGSCs and with Well-Root ST and ProRoot MTA in hDPSCs, although the differences did not reach statistical significance (p>0.05).
Tube formation assay
Statistically significant differences were noted in terms of tubular network formation by HUVECs, as follows: Well-Root ST>Biodentine>ProRoot MTA>Control>Dycal (p<0.05) ( Figure 6A, 6B ).
Discussion
In this study, due to the known contributions of PDGF, FGF-2, and VEGF to angiogenesis, their release was evaluated from odontogenic stem cells exposed to the tricalcium silicate-based materials Well-Root ST, Biodentine, and ProRoot MTA. 6 Untreated cells were used as a negative control group, and Dycal served as a positive control group because Dycal was previously shown to be cytotoxic to hTGSCs. 20
The MTS results showed no statistically significant difference between the hTGSC groups on the first Figure 4 -The visualized results of tested materials with ELISA test on different stem cell types for PDGF. hDPSCs: human dental pulp stem cells; hPLSCs: human periodontal ligament stem cells; hTGSCs: human tooth germ stem cells; PDGF: platelet-derived growth factor Figure 5 -The visualized results of tested materials with ELISA test on different stem cell types for VEGF. hDPSCs: human dental pulp stem cells; hPLSCs: human periodontal ligament stem cells; hTGSCs: human tooth germ stem cells; VEGF: vascular endothelial growth factor day, but the cell viability was higher on the third day in the Well-Root ST, Biodentine, and ProRoot MTA groups than in the positive control group. In the hDPSC groups, a statistically higher cell viability level was observed on the first day for the Well-Root ST group than for the ProRoot MTA and Dycal groups. In the hPLSC groups, a statistically higher viability was observed in the Well-Root ST group than in the positive control group on the third day. The Well-Root ST group also showed stable results at all time points in hPLSCs, although the cell viability varied in the ProRoot MTA and Biodentine groups during the experiment.
Our findings indicate that Well-Root ST, which is a newly developed tricalcium silicate-based material, is a suitable alternative to ProRoot MTA and Biodentine in terms of its potential for enhancing angiogenesis. Its effectiveness is likely due to its similar chemical components, as stated by the Well-Root ST manufacturer. The use of ProRoot MTA material in hDPSCs resulted in no significant change between the third day and the first day, but the increases in cell viability on the seventh, tenth, and fourteenth days were statistically significant. Conversely, the Well-Root ST treated hDPSCs showed no significant differences at any day, while the Biodentine group showed statistically significant increases on the fourteenth day.
After the 14-day period, all the tested materials were deemed biocompatible and all had good bioactivity, (2016) , who demonstrated that cells exposed to ProRoot MTA were well attached, with no inhibition zone observed around the cement at either day three or day seven.
The ELISA results also indicated no differences between the cell groups and the tested materials in terms of angiogenic-enhancing potential. A possible explanation for this effect could be differences in the test materials; that is, preparation of the cements in static conditions versus using extracts from set materials. Set materials in static conditions were used to recapitulate the long-term clinical conditions according to the manufacturers' instructions. 16, 24, 25 Consequently, the effect of the tested materials on cell behavior was similar and minor. Chung, et al. 23 (2016) found that VEGF levels were significantly higher in a ProRoot MTA group than in a control group, but no difference was found between the groups for Herein, HUVECs were used to show angiogenic potential by the tube formation assay, which is recognized as a basic vascularization model for in vitro studies. 12, 22, 27, 28 The tube formation assay results revealed that Well-Root ST, Biodentine, and ProRoot MTA all enhanced the HUVECs angiogenic potential.
Well-Root ST showed the best angiogenic response, which might be related to the higher tendency of cells treated with Well-Root ST to release VEGF, an essential factor for the vascular system differentiation at the first day in all cell types. In contrast to these results, Chang, et al. 27 (2015) reported that ProRoot MTA induced a significant increase in the expression of angiogenic genes and in capillary tube formation.
Costa, et al. 12 (2016) also showed that ProRoot MTA and Biodentine were not different in their abilities to increase HUVEC growth. 
